The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors.
Oberg
K
K
Department of Internal Medicine, University Hospital, Uppsala, Sweden.
Eriksson
B
B
Janson
E T
ET
D002276:Carcinoid Tumor / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D018358:Neuroendocrine Tumors / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins; D013274:Stomach Neoplasms / Q000628:therapy*
D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins